Improved Induction of Antibodies against Key Neutralizing Epitopes by Human Immunodeficiency Virus Type 1 gp120 DNA Prime-Protein Boost Vaccination Compared to gp120 Protein-Only Vaccination

作者: Michael Vaine , Shixia Wang , Emma T. Crooks , Pengfei Jiang , David C. Montefiori

DOI: 10.1128/JVI.00562-08

关键词:

摘要: A major challenge in human immunodeficiency virus type 1 (HIV-1) vaccine development is to elicit potent and broadly neutralizing antibodies that are effective against primary viral isolates. Previously, we showed DNA prime-protein boost vaccination using HIV-1 gp120 antigens was more eliciting isolates than a recombinant protein-only approach. In the current study, analyzed difference antibody specificities rabbit sera elicited by these two immunization regimens peptide enzyme-linked immunosorbent assay competitive capture assay. Our results indicate regimen protein-alone approach inducing target key domains: V3 loop CD4 binding site. particular, positive targeting several peptides overlap with known area were detected only DNA-primed sera. Different profiles of provide insight into mechanisms behind elicitation better approach, our support use this further optimize Env formulations for HIV development.

参考文章(51)
Emma T. Crooks, Penny L. Moore, Douglas Richman, James Robinson, Jeffrey A. Crooks, Michael Franti, Norbert Schülke, James M. Binley, Characterizing anti-HIV monoclonal antibodies and immune sera by defining the mechanism of neutralization. Human antibodies. ,vol. 14, pp. 101- 113 ,(2006) , 10.3233/HAB-2005-143-407
T C VanCott, J R Mascola, R W Kaminski, V Kalyanaraman, P L Hallberg, P R Burnett, J T Ulrich, D J Rechtman, D L Birx, Antibodies with specificity to native gp120 and neutralization activity against primary human immunodeficiency virus type 1 isolates elicited by immunization with oligomeric gp160. Journal of Virology. ,vol. 71, pp. 4319- 4330 ,(1997) , 10.1128/JVI.71.6.4319-4330.1997
Phillipe N. Nyambi, Miroslaw K. Gorny, Lisa Bastiani, Guido van der Groen, Constance Williams, Susan Zolla-Pazner, Mapping of Epitopes Exposed on Intact Human Immunodeficiency Virus Type 1 (HIV-1) Virions: a New Strategy for Studying the Immunologic Relatedness of HIV-1 Journal of Virology. ,vol. 72, pp. 9384- 9391 ,(1998) , 10.1128/JVI.72.11.9384-9391.1998
John R. Mascola, Gabriela Stiegler, Thomas C. VanCott, Hermann Katinger, Calvin B. Carpenter, Chris E. Hanson, Holly Beary, Deborah Hayes, Sarah S. Frankel, Deborah L. Birx, Mark G. Lewis, Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies Nature Medicine. ,vol. 6, pp. 207- 210 ,(2000) , 10.1038/72318
E John Coligan, Current protocols in immunology Greene Pub. Associates and Wiley-Interscience. ,(1991)
T Muster, F Steindl, M Purtscher, A Trkola, A Klima, G Himmler, F Rüker, H Katinger, A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1. Journal of Virology. ,vol. 67, pp. 6642- 6647 ,(1993) , 10.1128/JVI.67.11.6642-6647.1993
Robyn L. Stanfield, Ian A. Wilson, Structural studies of human HIV-1 V3 antibodies. Human antibodies. ,vol. 14, pp. 73- 80 ,(2006) , 10.3233/HAB-2005-143-404
A J Conley, J A Kessler, L J Boots, P M McKenna, W A Schleif, E A Emini, G E Mark, H Katinger, E K Cobb, S M Lunceford, S R Rouse, K K Murthy, The consequence of passive administration of an anti-human immunodeficiency virus type 1 neutralizing monoclonal antibody before challenge of chimpanzees with a primary virus isolate. Journal of Virology. ,vol. 70, pp. 6751- 6758 ,(1996) , 10.1128/JVI.70.10.6751-6758.1996
R. Hofmann-Lehmann, J. Vlasak, R.A. Rasmussen, S. Jiang, P.L. Li, T.W. Baba, D.C. Montefiori, B.J. Bernacky, T.A. Rizvi, R. Schmidt, L.R. Hill, M.E. Keeling, H. Katinger, G. Stiegler, L.A. Cavacini, M.R. Posner, R.M. Ruprecht, Postnatal pre- and postexposure passive immunization strategies: protection of neonatal macaques against oral simian-human immunodeficiency virus challenge. Journal of Medical Primatology. ,vol. 31, pp. 109- 119 ,(2002) , 10.1034/J.1600-0684.2002.01014.X